Modeled PD speed is a PK→PD construct describing how threshold placement, binding sensitivity, coupling geometry, and PD noise bands transform concentration trajectories for sildenafil and avanafil. “PD speed” refers strictly to modeled PK→PD behavior, not real-world effectiveness or onset. Threshold placement determines where a PK curve intersects a modeled PD boundary. Binding sensitivity determines how concentration differences are transformed into modeled binding differences. Coupling geometry determines how binding is mapped into downstream PD signals, shaping transition width, curvature, and slope. PD noise bands add an interpretation region around the transformed signal. PK parameters including absorption rate, absorption timing, solubility, gastric emptying, distribution loading, distribution geometry, clearance geometry, first-pass metabolism, bioavailability, Tmax geometry, and Cmax geometry generate concentration-time trajectories that PD parameters subsequently transform. Concentration-dependent clearance can further modify trajectory curvature before transformation. The resulting coordinate describes modeled PD transition geometry rather than an observed onset or performance measure.
PK geometry supplies the temporal and amplitude structure that enters PD-speed modeling. A faster modeled absorption rate steepens the rising phase, while earlier absorption timing shifts systemic input along the time axis. Solubility influences dissolution-driven availability, and gastric-emptying geometry controls when material reaches the absorptive environment. Absorption-window width determines whether input is concentrated or distributed across time. Distribution loading determines early central-compartment concentration, while distribution geometry controls compartmental spread and redistribution timing. Clearance geometry determines removal dynamics, and first-pass metabolism controls the systemic fraction represented by the model. Bioavailability scales systemic input, while concentration-dependent clearance can change curvature across the trajectory. These mechanisms interact: faster modeled absorption can be offset by faster modeled clearance, while broader distribution geometry can alter the temporal shape created by earlier absorption. PD-speed modeling receives this PK trajectory and applies threshold placement, binding sensitivity, coupling geometry, and noise-band transformation. The resulting coordinate remains model-defined.
PD geometry determines how PK differences become modeled PD-speed differences. Threshold placement can move the modeled boundary-crossing coordinate earlier or later without changing the underlying PK trajectory. Binding sensitivity can amplify or compress concentration differences after they enter the PD mapping. Coupling geometry determines whether downstream transitions are broad, narrow, steep, or shallow, while saturation can compress differences near the upper portion of a modeled signal. PD noise bands widen or narrow the interpretation region surrounding that signal without representing observed individual variability. Sildenafil and avanafil can therefore be represented by distinct parameter sets for absorption rate, absorption timing, solubility, gastric emptying, distribution loading, distribution geometry, clearance geometry, first-pass metabolism, bioavailability, Tmax geometry, and Cmax geometry. The same PD transformation can consequently produce different modeled speed coordinates from different PK inputs, while different PD parameterizations can transform similar PK inputs differently. These are PK→PD geometry relationships, not real-world effectiveness-onset predictions.
Threshold placement establishes the concentration boundary used to define a modeled PD transition. Its position determines where a parameterized PK trajectory enters the selected PD region, thereby shifting the modeled temporal coordinate without altering the underlying concentration curve. Binding sensitivity determines how strongly concentration changes are translated into modeled binding changes. Higher sensitivity can expand separation between transformed trajectories, while lower sensitivity can compress differences already present in PK space. Coupling geometry then maps binding into a downstream signal, with slope, curvature, and saturation controlling transition width and local shape. PD noise bands surround the transformed trajectory and can broaden or narrow the modeled interpretation region. Together, these parameters define PD-speed geometry independently of any real-world effectiveness interpretation. The same PK trajectory can produce different modeled speed coordinates under different threshold, sensitivity, and coupling assumptions. Conversely, distinct PK trajectories can converge after PD transformation when the mapping compresses their differences.
PD variability can be represented by systematically varying threshold placement, binding sensitivity, coupling slope, curvature, saturation, and noise-band width. A threshold shift changes the coordinate at which a modeled trajectory crosses the PD boundary. Sensitivity variation changes the amplitude separation generated from the same concentration difference. Coupling variation alters how rapidly the transformed signal changes across time, producing broader or narrower modeled transition regions. Noise-band variation changes the displayed interpretation envelope without introducing a claim about observed variability. When these parameters are sampled together, they generate a distribution of modeled PD-speed coordinates rather than a single fixed value. That distribution can be compared across sildenafil and avanafil parameterizations to examine how PK differences interact with alternative PD mappings. The resulting window represents parameter-space geometry: it describes how specified assumptions transform PK trajectories into PD coordinates. It does not constitute a real-world onset distribution or a prediction of individual timing.
| PD Domain | PD-Speed Interaction | Link |
|---|---|---|
| Threshold Placement | Earlier/later PD boundary. | onset time |
| Binding Sensitivity | Amplification/compression. | pk speed |
| Coupling Geometry | Slope-driven shaping. | peak time |
PK-speed modeling begins with a concentration-time trajectory generated from absorption, distribution, metabolism, bioavailability, and clearance parameters. Absorption rate controls the steepness of systemic input, while absorption timing positions that input along the temporal axis. Gastric emptying and solubility modify the modeled arrival and availability of absorbed material, while absorption-window width determines how concentrated the input profile becomes. Distribution loading controls early central availability, and distribution geometry determines movement between compartments. Redistribution timing can reshape the trajectory around transitional regions. Clearance geometry determines the balance between continuing input and removal, while first-pass metabolism changes the systemic fraction entering the modeled circulation. Bioavailability scales that systemic input. Tmax geometry identifies the modeled concentration maximum, and Cmax geometry describes its modeled amplitude. Concentration-dependent clearance can further alter trajectory curvature. The resulting PK curve is then supplied to the PD transformation layer, where threshold placement and coupling parameters convert concentration-space geometry into modeled PD-speed coordinates.
PK variability changes the input geometry available to the PD transformation. Altering absorption rate changes the steepness of the rising phase, while shifting absorption timing moves the input profile along the time axis. Changes in gastric-emptying geometry or solubility can redistribute modeled input across time, and changes in absorption-window width can broaden or concentrate that input. Distribution loading and distribution geometry reshape early and intermediate concentration patterns, while redistribution timing modifies compartmental transitions. Clearance geometry determines how removal interacts with ongoing input, and concentration-dependent clearance can introduce nonlinear curvature. First-pass metabolism and bioavailability alter the systemic amount represented by the trajectory. These PK variations can change Tmax and Cmax geometry before any PD transformation occurs. When the resulting curves pass through identical threshold, binding, and coupling functions, their modeled PD-speed coordinates can still differ because their underlying temporal shapes differ. Thus, PD-speed interpretation inherits structure from PK while remaining explicitly defined by the combined PK→PD parameterization.
| PK Domain | PD-Speed Effect | Link |
|---|---|---|
| Absorption Rate | Steeper rising phase. | absorption rate |
| Distribution Geometry | Compartmental spread. | distribution speed |
| Clearance | Removal geometry. | elimination speed |
Modeled PD-speed differences arise from the interaction between PK trajectory geometry and PD transformation parameters. On the PK side, absorption rate and timing determine the structure of systemic input, while gastric emptying, solubility, and absorption-window width shape when that input appears. Distribution loading, distribution geometry, and redistribution timing modify the concentration trajectory after entry. Clearance geometry and concentration-dependent clearance shape removal and curvature, while first-pass metabolism and bioavailability determine the systemic fraction represented by the model. Tmax and Cmax describe geometric features of the resulting trajectory. The PD layer then applies threshold placement, binding sensitivity, coupling geometry, and noise bands. Threshold position changes the modeled boundary-crossing coordinate; sensitivity changes concentration-to-binding transformation; coupling changes downstream slope and curvature; and noise bands alter the interpretation region. PD speed is therefore an emergent model coordinate produced by these interacting parameter sets.
PK mechanisms shape PD-speed input by determining the concentration-time trajectory supplied to the PD transformation. Absorption rate controls rising-phase steepness, while absorption timing establishes temporal alignment. Gastric emptying and solubility affect the timing and availability of absorbed material, and absorption-window width controls how concentrated or distributed the modeled input becomes. Distribution loading determines early central availability, while distribution geometry describes movement across modeled compartments. Redistribution timing modifies later trajectory shape. Clearance geometry determines removal relative to ongoing input, and concentration-dependent clearance can produce nonlinear curvature. First-pass metabolism changes the systemic fraction available to the modeled circulation, while bioavailability scales that input. Tmax geometry identifies the modeled concentration maximum and Cmax geometry describes its amplitude. These mechanisms establish the PK curve before PD transformation occurs. Consequently, changes in any relevant PK parameter can alter the temporal or amplitude structure that threshold placement, binding sensitivity, and coupling geometry subsequently transform.
Four principal PD constructs shape modeled PD-speed geometry: threshold placement, binding sensitivity, coupling geometry, and PD noise bands. Threshold placement defines the concentration boundary used by the model and therefore determines where a trajectory enters the selected PD region. Binding sensitivity controls how concentration differences are translated into modeled binding differences, potentially expanding or compressing separation between trajectories. Coupling geometry maps binding into a downstream signal and determines how slope, curvature, and saturation reshape temporal transitions. PD noise bands add an interpretation envelope around the modeled signal and can broaden or narrow the apparent coordinate region. These mechanisms operate after the PK trajectory has been generated. Their effects are therefore transformations of existing concentration geometry rather than independent PK processes. Different parameterizations can convert similar PK trajectories into different modeled PD-speed coordinates, while different PK trajectories can become more similar under a compressive PD mapping. The resulting construct remains mathematical and mechanistic.
Sildenafil and avanafil can produce different modeled PD-speed coordinates when their parameterized PK or PD representations differ. PK differences can occur in modeled absorption rate, absorption timing, solubility, gastric emptying, absorption-window width, distribution loading, distribution geometry, redistribution timing, clearance geometry, first-pass metabolism, bioavailability, Tmax geometry, Cmax geometry, or concentration-dependent clearance. Each difference can alter the concentration trajectory supplied to the PD layer. PD parameters can then modify how those trajectories are represented: threshold placement changes boundary-crossing coordinates, binding sensitivity changes concentration-to-binding separation, and coupling geometry changes downstream slope and curvature. Noise bands can alter the width of the modeled interpretation region. A parameter difference may therefore be amplified by one transformation and compressed by another. The resulting sildenafil-versus-avanafil comparison describes the geometry produced by the specified parameter sets. It does not establish an observed timing difference, real-world effectiveness onset, or any patient-level outcome.
PK→PD mapping explains modeled PD-speed differences by treating concentration generation and PD transformation as sequential but interacting layers. The PK layer generates a concentration-time trajectory from absorption, distribution, metabolism, bioavailability, and clearance parameters. Tmax and Cmax represent geometric features of that trajectory. The PD layer then applies threshold placement, binding sensitivity, coupling geometry, and noise bands to transform concentration into a modeled signal. Because the transformation can be nonlinear, a small PK shift can become larger, smaller, or differently shaped after PD conversion. Thresholds can reposition modeled boundary crossings, sensitivity can amplify or compress concentration differences, and coupling geometry can broaden or narrow downstream transitions. Noise bands can further change the width of the modeled interpretation region. Comparing sildenafil and avanafil therefore involves comparing both their PK trajectories and the PD functions applied to those trajectories. PD speed is consequently an emergent coordinate of the complete mathematical mapping, not a direct measure of real-world onset or effectiveness.